Based on the aggregated intelligence of 170,000-plus investors participating in Motley Fool CAPS, the Fool's free investing community, female condom maker Female Health
With that in mind, let's take a closer look at Female Health's business and see what CAPS investors are saying about the stock right now.
Female Health facts
|Headquarters (Founded)||Chicago (1896)|
|Market Cap||$131.5 million|
|Trailing-12-Month Revenue||$20.38 million|
Chairman/CEO O. B. Parrish
CFO Donna Felch
|Return on Capital (Average, Past 3 Years)||29.2%|
|Cash/Debt||$3.64 million / $9,000|
Church & Dwight
Sources: Capital IQ (a division of Standard & Poor's) and Motley Fool CAPS.
Just last month, BuffettJunior1 touched on Female Health's solid fundamentals:
Its not trading at a discount, but its still trading at an attractive price. ... What really impresses me about this company is its high return on capital. I'm always willing to pay more for companies with high return on capital, because they almost always outperform the market in the long run.
In fact, Female Health's three-year average return on capital of 29.2% tops that of rival condom maker Church & Dwight (11.1%), as well as other personal products stocks like Procter & Gamble
CAPS member StockEse expands on the outperform argument:
HIV/AIDS, other STDs, and unplanned/unwanted pregnancy are often linked to women's difficulty in negotiating condom use with partners. The female condom allows women to sidestep the negotiation entirely, taking matters into their own hands. ... FHCO has a huge potential market and could very well make enormous gains over time.
More importantly: Solid fundamentals, steady growth, no long term debt.
What do you think about Female Health, or any other stock for that matter? If you want to retire rich, you need to put together the best portfolio you can. Owning exceptional stocks is a surefire way to secure your financial future, and on Motley Fool CAPS, thousands of investors are working every day to find them. CAPS is 100% free, so get started!
Fool contributor Brian Pacampara owns no position in any of the companies mentioned. Female Health is a Motley Fool Global Gains pick. Procter & Gamble and Kimberly-Clark are choices of Income Investor. Try any of our Foolish newsletter services free for 30 days.
More from The Motley Fool
My 3 Worst Stocks for 2013
These three companies made minimal gains over the past year. But here's why this Fool is sticking with them.
Female Health Beats Estimates on Q4 EPS
Female Health well exceeds the average analyst estimate of $0.14 for quarterly EPS.
Is Female Health Destined for Greatness?
Let's see what the numbers say about Female Health.